Headline
The latest stories from AHA Today.
The Food and Drug Administration today authorized Moderna鈥檚 COVID-19 vaccine for children aged 6 months through 17 years old and Pfizer鈥檚 COVID-19 vaccine for children aged 6 months through 4 years old, as recommended this week by its vaccine advisory committee.
A new special issue of Health Services Research focuses on how health care organizations can use implementation science and community-engaged research methods to improve population health and reduce care disparities.
鈥淯nderstanding potential costs is an important part of the patient experience when planning for care, and hospitals and health systems are committed to helping patients navigate that process,鈥 writes Ari Levin, AHA鈥檚 director of coverage policy.
The Centers for Medicare & Medicaid Services today approved state plan amendments allowing Maine, Minnesota, New Mexico and Washington, D.C., to extend postpartum coverage from 60 days to 12 months after pregnancy for Medicaid and Children鈥檚 Health Insurance Program enrollees under the American鈥
COVID-19 hospitalization rates are about 50% higher for adults eligible for Medicare because of a disability than for other adults enrolled in Medicare.
President Biden yesterday directed the Health and Human Services Secretary to develop and release sample policies for states 鈥渢o safeguard and expand access to health care for LGBTQI+ individuals and their families, including mental health services.鈥
A Food and Drug Administration advisory committee today recommended the agency authorize Moderna鈥檚 COVID-19 two-dose vaccine for children aged 6 months through 5 years old and Pfizer鈥檚 three-dose COVID-19 vaccine for children aged 6 months through 4 years old
The National Center for Healthcare Leadership is accepting nominations through July 8 for the 2022 Gail L. Warden Leadership Excellence Award.
The Food and Drug Administration Friday authorized the first COVID-19 test to identify and differentiate certain SARS-CoV-2 lineages in respiratory samples that test positive for the virus.
The Centers for Disease Control and Prevention yesterday updated its guidance to help clinicians evaluate and test patients with relevant history, signs and symptoms for monkeypox